Evidence map›Paper›PMID 29970872›Full record

ArticleMolecules (Basel, Switzerland)2018

Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid.

Evangelia Tsolaki, Phaedra Eleftheriou, Victor Kartsev, Athina Geronikaki, Anil K Saxena

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Approaches Towards Better Immunosuppressive Agents.Current topics in medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biomolecules · 2020
    Article
  9. Article
  10. 4,5-Diaryl 3(Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Evangelia TsolakiDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. evantsol@yahoo.gr.ORCID 0000-0002-9876-0707
Phaedra EleftheriouDepartment of Medical Laboratories, School of Health and Care Professions, Alexander Technological Educational Institute of Thessaloniki, 54700 Thessaloniki, Greece. eleftheriouphaedra@gmail.com.
Victor KartsevInterBioscreen, 119019 Moscow, Russia. vkartsev@ibscreen.chg.ru.
Athina GeronikakiDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. geronik@pharm.auth.gr.
Anil K SaxenaDivision of Medicinal & Process Chemistry, Central Drug Research Institute, 226031 Lucknow, India. anilsak@gmail.com.
Aristotle University of Thessaloniki · GRAlexander Technological Educational Institute of Thessaloniki · GRCentral Drug Research Institute · INTransgenomic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-LOX inhibition is among the desired characteristics of anti-inflammatory drugs, while 15-LOX has also been considered as a drug target. Similarity in inhibition behavior between soybean LOX-1 and human 5-LOX has been observed and soybean LOX (sLOX) type 1b has been used for the evaluation of LOX inhibition in drug screening for years. After prediction of LOX inhibition by PASS and docking as well as toxicity by PROTOX and ToxPredict sixteen (

Indexed as

CaproatesDrug DesignGlycine maxHumansLipoxygenaseLipoxygenase InhibitorsMolecular Docking SimulationMolecular StructureMycophenolic AcidPlant ProteinsStructure-Activity RelationshipCaproatesLipoxygenaseLipoxygenase InhibitorsMycophenolic AcidPlant Proteinsanti-inflammatorydockingLOXpharmacophorethiazoles

Identifiers

PMID29970872
PMCPMC6099768
OpenAlexW2811200203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.